australia's next csl?, page-15

"A higher healing rate would be expected using a normal population of ulcer sufferers".

"... your comments appear to be pure 'speculation'..."

Bumskins,

You could call it speculation. It's also an educated assumption.

The patients on the previous trials were not responding to other treatments, so they were selected difficult cases (as proven by their lack of response and (in some cases) worsening conditions).

The current trial is likely to be a more normal cross section of cases. One can speculate that the results will be better with the new trial with a little confidence I feel. The new formulation will give a more even mixture of ingredients too.